EFFECTS ON DOSE COEFFICIENTS FOR WORKERS OF RECENT CHANGES IN INTERNAL DOSIMETRY

Citation
Tj. Silk et al., EFFECTS ON DOSE COEFFICIENTS FOR WORKERS OF RECENT CHANGES IN INTERNAL DOSIMETRY, Radiation protection dosimetry, 71(1), 1997, pp. 7-21
Citations number
14
Categorie Soggetti
Radiology,Nuclear Medicine & Medical Imaging","Nuclear Sciences & Tecnology
ISSN journal
01448420
Volume
71
Issue
1
Year of publication
1997
Pages
7 - 21
Database
ISI
SICI code
0144-8420(1997)71:1<7:EODCFW>2.0.ZU;2-B
Abstract
The International Commission on Radiological Protection (ICRP) has rec ently reviewed and updated, in ICRP Publications 56, 67 and 69, some o f the biokinetic models of ICRP Publication 30. As well as this, ICRP has adopted a new model for the human respiratory tract, the details o f which were issued as ICRP Publication 66. A compendium of dose coeff icients (dose per unit intake values) for workers based on the new lun g model, and some new recommendations on systemic models, has been iss ued in ICRP Publication 68. Doses for inhalation of 1 and 5 mu m Activ ity Median Aerodynamic Diameter (AMAD) aerosols and for ingestion are given here for a selection of important nuclides, using the latest lun g and systemic models. The results are compared with those of previous models. The new Absorption Types F, M, S (Fast, Moderate and Slow) ar e compared with the old inhalation Classes D, W, Y (for retention peri ods Days, Weeks, Years). It is found that generally the dominating fac tor for Types F and S is the lower overall deposition in the new model , leading to lower doses. Type M material is retained in the lung for much longer than Class W material of the ICRP Publication 30 model. Th is overrides the lower deposition and lung doses are higher in most ca ses. For 5 mu m aerosols (the new default for occupational exposure) t he activity reaching blood for Types F and M is similar to that for 1 mu m (the previous default) Class D and W aerosols. However, the amoun t for Type S is only around 10% of that for Class Y. Doses to systemic tissues are reduced accordingly. A detailed investigation of systemic uptake is given in the Appendix. Further changes in systemic tissue d oses are caused by some substantial changes to biokinetic models. Comm itted effective doses are generally lower although there are some exce ptions. Differences in doses by ingestion are more simply explained by changes to systemic models and some other relatively minor changes.